Chesapeake Wealth Management Bio Rad Laboratories, Inc. Transaction History

Chesapeake Wealth Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$463.67 - $597.16 $642,646 - $827,663	-1,386 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$524.57 - $735.42 $2,622 - $3,677	5 Added 0.36%	1,386 $781,000
Q4 2021 Feb 03, 2022	BUY	$708.84 - $794.68 $53,163 - $59,600	75 Added 5.74%	1,381 $1.04 Million
Q3 2021 Oct 26, 2021	SELL	$657.71 - $825.77 $68,401 - $85,880	-104 Reduced 7.38%	1,306 $974,000
Q2 2021 Jul 29, 2021	SELL	$576.64 - $649.04 $30,561 - $34,399	-53 Reduced 3.62%	1,410 $909,000
Q1 2021 Apr 26, 2021	BUY	$547.01 - $662.35 $162,461 - $196,717	297 Added 25.47%	1,463 $836,000
Q4 2020 Feb 05, 2021	BUY	$510.68 - $643.45 $26,555 - $33,459	52 Added 4.67%	1,166 $680,000
Q3 2020 Nov 12, 2020	BUY	$454.43 - $535.6 $107,245 - $126,401	236 Added 26.88%	1,114 $574,000
Q2 2020 Aug 11, 2020	BUY	$334.87 - $493.06 $294,015 - $432,906	878 New	878 $396,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Chesapeake Wealth Management with notifications on news.